We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

125 hedge funds and large institutions have $2.82B invested in PRA Health Sciences, Inc. in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

18% more funds holding

Funds holding: 106125 (+19)

16% more capital invested

Capital invested by funds: $2.42B → $2.82B (+$399M)

5% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 40

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

91% less call options, than puts

Call options by funds: $48K | Put options by funds: $548K

Holders
125
Holders Change
+19
Holders Change %
+17.92%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
42
Reduced
40
Closed
8
Calls
$48K
Puts
$548K
Net Calls
-$500K
Net Calls Change
-$569K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$6M +$534K +12,704 +11%
SI
27
Scout Investments
Missouri
$5.69M -$729K -17,350 -12%
American Century Companies
28
American Century Companies
Missouri
$5.67M -$1.09M -25,853 -17%
SIM
29
Spark Investment Management
New York
$5.5M -$592K -14,100 -10%
RFC
30
Russell Frank Company
Washington
$4.18M +$3.21M +76,485 +640%
Arrowstreet Capital
31
Arrowstreet Capital
Massachusetts
$4.17M +$2.81M +66,800 +264%
PC
32
Pier Capital
Connecticut
$3.93M -$90.7K -2,160 -2%
TCIM
33
TIAA CREF Investment Management
New York
$3.88M -$1.32M -31,382 -27%
Invesco
34
Invesco
Georgia
$3.85M -$695K -16,531 -16%
Natixis Advisors
35
Natixis Advisors
Massachusetts
$3.67M -$4.47M -106,505 -57%
Bank of America
36
Bank of America
North Carolina
$3.56M +$201K +4,779 +6%
BIM
37
BlackRock Investment Management
Delaware
$3.02M +$8.49K +202 +0.3%
GCP
38
GSA Capital Partners
United Kingdom
$2.92M +$102K +2,438 +4%
Charles Schwab
39
Charles Schwab
California
$2.84M +$78.5K +1,868 +3%
PAM
40
Panagora Asset Management
Massachusetts
$2.83M +$2.56M +60,894 +3,782%
Asset Management One
41
Asset Management One
Japan
$2.6M +$2.05M +48,835 +562%
Neuberger Berman Group
42
Neuberger Berman Group
New York
$2.55M +$2.37M +56,294 New
First Trust Advisors
43
First Trust Advisors
Illinois
$2.45M +$453K +10,780 +25%
SCM
44
Sandler Capital Management
New York
$2.4M -$714K -17,000 -24%
Wells Fargo
45
Wells Fargo
California
$2.34M -$653K -15,542 -23%
ProShare Advisors
46
ProShare Advisors
Maryland
$2.32M +$2.16M +51,333 New
UBS Group
47
UBS Group
Switzerland
$2.13M -$527K -12,547 -21%
QI
48
QS Investors
New York
$2.13M +$1.97M +47,006 New
AI
49
Analytic Investors
California
$1.92M -$686K -16,333 -28%
Federated Hermes
50
Federated Hermes
Pennsylvania
$1.83M +$832K +19,812 +96%

PRAH Hedge Fund Activity: Q4 2015 in Review

125 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q4 2015, worth a combined $2.82B — up 16% from $2.42B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PRAH positions and 8 closed out — a net gain of 19 holders — while 42 added to existing stakes and 40 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $30M. The largest seller was Vaughan Nelson Investment Management, cutting an estimated $35M.

  • 125 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q4 2015, up from 106 in Q3 2015.
  • Funds reported $2.82B of PRA Health Sciences, Inc. stock for Q4 2015, up 16% quarter-over-quarter.
  • 27 funds opened new PRA Health Sciences, Inc. positions in Q4 2015 and 8 closed out, a net change of +19 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $30M added.
  • The largest PRA Health Sciences, Inc. seller in Q4 2015 was Vaughan Nelson Investment Management, an estimated $35M sold.

Based on aggregated 13F filings for Q4 2015.